Thursday, July 23, 2020 10:03:53 PM
“It seems that Steve King and Mateon have been getting some attention lately and when is the PR scheduled for the Covid-19 Clinical trial and CA4P just another surprise pending - as Steve King was collaborating long ago with OXiGene ( name changed to Mateon ) and Oncotelic founders know well of Celgene / Abraxane ties : this all leads quite the run up from .25 and instant $1+ stock. “
OT-101 is also being deployed as anti-COVID-19 agent. The IND for COVID-19 has been submitted and we plan to initiate the clinical trial as soon as possible.
http://investor.mateon.com/news-releases/news-release-details/fda-grants-pediatric-disease-designation-mateons-ca4p
Recent OTLC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 10:00:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 01:00:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 02:30:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 09:00:34 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/13/2023 01:25:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 01:15:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 01:25:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM